Quantification of tipranavir in human plasma by high-performance liquid chromatography with UV detection

被引:18
作者
Giraud, E [1 ]
Rey, E [1 ]
Tréluyer, JM [1 ]
Pons, G [1 ]
Jullien, V [1 ]
机构
[1] Univ Paris Descartes, AP HP, Grp Hosp Cochin St Vincent de Paul, Fac Med,Pharmacol Clin, Paris, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2006年 / 830卷 / 01期
关键词
tipranavir; liquid chromatography; UV detection;
D O I
10.1016/j.jchromb.2005.10.024
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple method for the quantification of tipranavir, a new non-peptidic protease-inhibitor, was developed. An internal standard, prazepam, was added to 100 mu l of plasma before a liquid-liquid extraction by 3 ml of tert-butyl methyl ether. The extracts were evaporated to dryness and reconstituted with 100 mu l of mobile phase before being injected in the chromatographic system. The separation was made on a C8 column using sodium acetate buffer (pH 5): methanol: acetonitrile (35:30:35, v/v/v) as mobile phase. The detection was performed at a wavelength of 260 nm. The method was linear and has been validated over a concentration range of 2-80 mgA. The mean precision and accuracy of the method were respectively, 10.5 and -9.1%. The mean recovery was 70.8%. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:86 / 90
页数:5
相关论文
共 9 条
[1]  
Chaix C, 2000, J ACQ IMMUN DEF SYND, V24, P227
[2]  
COOPER D, 2003, P 10 C RETR OPP INF
[3]   The influence of age and sex on the clearance of cytochrome P450 3A substrates [J].
Cotreau, MM ;
von Moltke, LL ;
Greenblatt, DJ .
CLINICAL PHARMACOKINETICS, 2005, 44 (01) :33-60
[4]   Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry [J].
Crommentuyn, KML ;
Rosing, H ;
Hillebrand, MJX ;
Huitema, ADR ;
Beijnen, JH .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 804 (02) :359-367
[5]  
GATHE J, 2003, P 10 C RETR OPP INF
[6]   Practical guidelines to interpret plasma concentrations of antiretroviral drugs [J].
Kappelhoff, BS ;
Crommentuyn, KML ;
de Maat, MMR ;
Mulder, JW ;
Huitema, ADR ;
Beijnen, JH .
CLINICAL PHARMACOKINETICS, 2004, 43 (13) :845-853
[7]  
MCCALLISTER S, 2002, P 11 INT HIV DRUG RE
[8]  
YENI P, 2003, P 10 C RETR OPP INF
[9]  
YENI P, 2003, J ACQ IMMUN DEF SYND, V34, P91